Review: Toxicometabolomics

Metabolomics use in toxicology is rapidly increasing, particularly owing to advances in mass spectroscopy, which is widely used in the life sciences for phenotyping disease states. Toxicology has the advantage of having the disease agent, the toxicant, available for experimental induction of metabolomics changes monitored over time and dose. This review summarizes the different technologies employed and gives examples of their use in various areas of toxicology. A prominent use of metabolomics is the identification of signatures of toxicity – patterns of metabolite changes predictive of a hazard manifestation. Increasingly, such signatures indicative of a certain hazard manifestation are identified, suggesting that certain modes of action result in specific derangements of the metabolism. This might enable the deduction of underlying pathways of toxicity, which, in their entirety, form the Human Toxome, a key concept for implementing the vision of Toxicity Testing for the 21st century. This review summarizes the current state of metabolomics technologies and principles, their uses in toxicology and gives a thorough overview on metabolomics bioinformatics, pathway identification and quality assurance. In addition, this review lays out the prospects for further metabolomics application also in a regulatory context. Copyright © 2013 John Wiley & Sons, Ltd.

[1]  R. Ramautar,et al.  CE‐MS for metabolomics: Developments and applications in the period 2012–2014 , 2015, Electrophoresis.

[2]  T. Murdoch,et al.  Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy. , 2013, Journal of Crohn's & colitis.

[3]  Deepali Chavan,et al.  Analytical Method Development and Validation , 2012 .

[4]  H. Kamp,et al.  Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR. , 2012, Mutation research.

[5]  M. Arbushites,et al.  Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: A pilot study , 2012, Molecular oncology.

[6]  T. Takenawa,et al.  A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer , 2012, PloS one.

[7]  X. Correig,et al.  Metabolomics Approach for Analyzing the Effects of Exercise in Subjects with Type 1 Diabetes Mellitus , 2012, PloS one.

[8]  S. Hazen,et al.  Translating metabolomics to cardiovascular biomarkers. , 2012, Progress in cardiovascular diseases.

[9]  Mardas Daneshian,et al.  Validation and quality control of replacement alternatives - Current status and future challenges , 2012 .

[10]  Xinmin Yin,et al.  Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease. , 2012, Journal of proteome research.

[11]  Lutgarde M. C. Buydens,et al.  Interpretation and Visualization of Non-Linear Data Fusion in Kernel Space: Study on Metabolomic Characterization of Progression of Multiple Sclerosis , 2012, PloS one.

[12]  M. Waters,et al.  Investigating Potential Mechanisms of Obesity by Metabolomics , 2012, Journal of biomedicine & biotechnology.

[13]  G. Siuzdak,et al.  XCMS Online: a web-based platform to process untargeted metabolomic data. , 2012, Analytical chemistry.

[14]  David S. Wishart,et al.  MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis , 2012, Nucleic Acids Res..

[15]  W. Xue,et al.  NMR-based Metabolomic Analysis of Human Bladder Cancer , 2012, Analytical Sciences.

[16]  Scarlet F. Brockmöller,et al.  Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery , 2012, Genome Medicine.

[17]  Julian L Griffin,et al.  Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer , 2012, Genome Medicine.

[18]  M. Shannon,et al.  Serum metabolomic profiles from patients with acute kidney injury: a pilot study. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[19]  Hui Sun,et al.  Urine Metabolomics Analysis for Biomarker Discovery and Detection of Jaundice Syndrome in Patients With Liver Disease* , 2012, Molecular & Cellular Proteomics.

[20]  F. Di Virgilio,et al.  Expression of P2X7 receptor increases in vivo tumor growth. , 2012, Cancer research.

[21]  T. Shuin,et al.  Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer. , 2012, Biological & pharmaceutical bulletin.

[22]  A. Goesmann,et al.  MSEA: metabolite set enrichment analysis in the MeltDB metabolomics software platform: metabolic profiling of Corynebacterium glutamicum as an example , 2012, Metabolomics.

[23]  J. Lindon,et al.  Pharmacometabonomic investigation of dynamic metabolic phenotypes associated with variability in response to galactosamine hepatotoxicity. , 2012, Journal of proteome research.

[24]  Masaru Tomita,et al.  Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis , 2012, Current bioinformatics.

[25]  Cécile Legallais,et al.  Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs. , 2012, Analytical chemistry.

[26]  H. Ressom,et al.  LC-MS-based metabolomics. , 2012, Molecular bioSystems.

[27]  J. Lindon,et al.  Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy , 2012, Expert opinion on drug metabolism & toxicology.

[28]  J. Klawitter,et al.  Bezielle (BZL101)‐induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: A combined proteomic and metabolomic study , 2011, International journal of cancer.

[29]  Vladimir N. Uversky,et al.  Analyzing and Mapping Sweat Metabolomics by High-Resolution NMR Spectroscopy , 2011, PloS one.

[30]  Deborah I. Bunin,et al.  Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced hepatotoxicity. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[31]  T. Veenstra,et al.  Global proteomics and metabolomics in cancer biomarker discovery. , 2011, Journal of separation science.

[32]  Chris T. A. Evelo,et al.  WikiPathways: building research communities on biological pathways , 2011, Nucleic Acids Res..

[33]  D J Dix,et al.  Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics. , 2011, Toxicology and applied pharmacology.

[34]  Laura K. Schnackenberg,et al.  Metabolomics in Systems Toxicology: Towards Personalized Medicine , 2011 .

[35]  E. Fukusaki,et al.  Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat. , 2011, Toxicology.

[36]  R. Weiss,et al.  Urine metabolomics for kidney cancer detection and biomarker discovery. , 2011, Urologic oncology.

[37]  Nicola Zamboni,et al.  High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry. , 2011, Analytical chemistry.

[38]  Zhi Chen,et al.  Revised Papers , 2022 .

[39]  Jianke Ren,et al.  Metabolomic analysis of normal (C57BL/6J, 129S1/SvImJ) mice by gas chromatography-mass spectrometry: detection of strain and gender differences. , 2011, Talanta.

[40]  Matej Oresic,et al.  MPEA - metabolite pathway enrichment analysis , 2011, Bioinform..

[41]  Robert Landsiedel,et al.  Linking energy metabolism to dysfunctions in mitochondrial respiration--a metabolomics in vitro approach. , 2011, Toxicology letters.

[42]  Hongde Liu,et al.  Metabolomic analysis of liver and skeletal muscle tissues in C57BL/6J and DBA/2J mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 2011, Molecular bioSystems.

[43]  Y. Choi,et al.  NMR-based plant metabolomics: where do we stand, where do we go? , 2011, Trends in biotechnology.

[44]  Arjen Lommen,et al.  An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin , 2011, BMC Genomics.

[45]  Jie Lu,et al.  Profiling the reactive metabolites of xenobiotics using metabolomic technologies. , 2011, Chemical research in toxicology.

[46]  Xiaohua Wu,et al.  Serum 27-nor-5β-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. , 2011, Journal of proteome research.

[47]  Thomas Hartung,et al.  From alternative methods to a new toxicology. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[48]  Thomas Szyperski,et al.  Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe. , 2011, Journal of proteome research.

[49]  B. Fromenty,et al.  Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. , 2011, Journal of hepatology.

[50]  P. Meikle,et al.  A lipidomic screen of palmitate-treated MIN6 β-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. , 2011, The Biochemical journal.

[51]  Taisen Iguchi,et al.  Metabolomics Reveals Target and Off-Target Toxicities of a Model Organophosphate Pesticide to Roach (Rutilus rutilus): Implications for Biomonitoring , 2011, Environmental science & technology.

[52]  Donald G Robertson,et al.  Metabolomics in toxicology: preclinical and clinical applications. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  M. Milburn,et al.  Plasma metabolomic profile in nonalcoholic fatty liver disease. , 2011, Metabolism: clinical and experimental.

[54]  M. Kohno,et al.  Metabolomic analysis of human plasma from haemodialysis patients , 2011, European journal of clinical investigation.

[55]  Jianmin Zhao,et al.  Toxicological responses to acute mercury exposure for three species of Manila clam Ruditapes philippinarum by NMR-based metabolomics. , 2011, Environmental toxicology and pharmacology.

[56]  Xiaomei Yan,et al.  LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery. , 2011, Journal of proteome research.

[57]  Rawi Ramautar,et al.  CE‐MS for metabolomics: Developments and applications in the period 2008–2010 , 2011, Electrophoresis.

[58]  Ting Zhang,et al.  Dose dependent in vivo metabolic characteristics of titanium dioxide nanoparticles. , 2010, Journal of nanoscience and nanotechnology.

[59]  M. K. Alam,et al.  1H NMR-based metabonomic investigation of tributyl phosphate exposure in rats. , 2010, Toxicology letters.

[60]  Meric A. Ovacik,et al.  Transcriptional and metabolic flux profiling of triadimefon effects on cultured hepatocytes. , 2010, Toxicology and applied pharmacology.

[61]  Asaph Aharoni,et al.  Evaluation of peak picking quality in LC-MS metabolomics data. , 2010, Analytical chemistry.

[62]  M. Sawyer,et al.  Urine Metabolite Analysis Offers Potential Early Diagnosis of Ovarian and Breast Cancers , 2010, Clinical Cancer Research.

[63]  E. Schleicher,et al.  Insulin Sensitivity Is Reflected by Characteristic Metabolic Fingerprints - A Fourier Transform Mass Spectrometric Non-Targeted Metabolomics Approach , 2010, PloS one.

[64]  David S. Wishart,et al.  Bioinformatics Applications Note Systems Biology Metpa: a Web-based Metabolomics Tool for Pathway Analysis and Visualization , 2022 .

[65]  Jens O Krömer,et al.  Towards quantitative metabolomics of mammalian cells: development of a metabolite extraction protocol. , 2010, Analytical biochemistry.

[66]  Guy Brock,et al.  Polychlorinated Biphenyls, Lead, and Mercury Are Associated with Liver Disease in American Adults: NHANES 2003–2004 , 2010, Environmental health perspectives.

[67]  P. West,et al.  Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. , 2010, Toxicology and applied pharmacology.

[68]  Yuqin Wang,et al.  Targeted metabolomics for biomarker discovery. , 2010, Angewandte Chemie.

[69]  Matej Oresic,et al.  MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data , 2010, BMC Bioinformatics.

[70]  Q. Zhan,et al.  Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer. , 2010, Journal of proteome research.

[71]  R. Heeren,et al.  A concise review of mass spectrometry imaging. , 2010, Journal of chromatography. A.

[72]  Manuel Liebeke,et al.  A protocol for the investigation of the intracellular Staphylococcus aureus metabolome. , 2010, Analytical biochemistry.

[73]  David S. Wishart,et al.  MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data , 2010, Nucleic Acids Res..

[74]  Daniel Raftery,et al.  Quantitative Metabolomics by 1H-NMR and LC-MS/MS Confirms Altered Metabolic Pathways in Diabetes , 2010, PloS one.

[75]  C. Klampfl CE‐MS , 2010, Electrophoresis.

[76]  Qian Bu,et al.  NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration , 2010, Nanotechnology.

[77]  A. Ziegler,et al.  An Extensive Comparison of Quantitative Trait Loci Mapping Methods , 2010, Human Heredity.

[78]  Richard D Beger,et al.  Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. , 2010, Toxicology and applied pharmacology.

[79]  Mitsutoshi Setou,et al.  Imaging Mass Spectrometry for Visualization of Drug and Endogenous Metabolite Distribution: Toward In Situ Pharmacometabolomes , 2010, Journal of Neuroimmune Pharmacology.

[80]  Jong Hwan Sung,et al.  A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. , 2010, Lab on a chip.

[81]  M. Viant,et al.  Identifying health impacts of exposure to copper using transcriptomics and metabolomics in a fish model. , 2010, Environmental science & technology.

[82]  Jun Han,et al.  Mass spectrometry-based technologies for high-throughput metabolomics. , 2009, Bioanalysis.

[83]  Michael A Kennedy,et al.  NMR‐based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad‐spectrum antibiotic enrofloxacin (Baytril) , 2009, Magnetic resonance in chemistry : MRC.

[84]  Ulo Langel,et al.  Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling. , 2009, Toxicology.

[85]  Christian Lanz,et al.  The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. , 2009, Mass spectrometry reviews.

[86]  M. Beal,et al.  Metabolomic Profiling in LRRK2-Related Parkinson's Disease , 2009, PloS one.

[87]  W. R. Wikoff,et al.  Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data. , 2009, Analytical chemistry.

[88]  Hanne Christine Bertram,et al.  Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification. , 2009, Analytical chemistry.

[89]  Thomas Hartung,et al.  Chemical regulators have overreached , 2009, Nature.

[90]  W. Humphreys,et al.  Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans , 2009, Drug Metabolism and Disposition.

[91]  T. Hartung Toxicology for the twenty-first century , 2009, Nature.

[92]  Yong Wang,et al.  Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats , 2009, Neurochemistry International.

[93]  Oliver Fiehn,et al.  Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research , 2009, Metabolomics.

[94]  A. Mally,et al.  Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery. , 2009, Chemical research in toxicology.

[95]  Thomas Hankemeier,et al.  Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics , 2009, Metabolomics.

[96]  David S. Wishart,et al.  MetaboAnalyst: a web server for metabolomic data analysis and interpretation , 2009, Nucleic Acids Res..

[97]  Stephen W. Edwards,et al.  Endocrine disrupting chemicals in fish: developing exposure indicators and predictive models of effects based on mechanism of action. , 2009, Aquatic toxicology.

[98]  Arjen Lommen,et al.  MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. , 2009, Analytical chemistry.

[99]  Han Min Woo,et al.  Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[100]  Suryanarayana V Vulimiri,et al.  Effects of mainstream cigarette smoke on the global metabolome of human lung epithelial cells. , 2009, Chemical research in toxicology.

[101]  S. Eckhardt,et al.  Clinical Applications of Metabolomics in Oncology: A Review , 2009, Clinical Cancer Research.

[102]  R. Ramautar,et al.  CE‐MS in metabolomics , 2009, Electrophoresis.

[103]  Jens Stoye,et al.  MeltDB: a software platform for the analysis and integration of metabolomics experiment data , 2008, Bioinform..

[104]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[105]  D. Raftery,et al.  Metabolomics-based methods for early disease diagnostics , 2008, Expert review of molecular diagnostics.

[106]  Christophe Junot,et al.  Mass spectrometry for the identification of the discriminating signals from metabolomics: current status and future trends. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[107]  Kathleen A Stringer,et al.  Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[108]  D. Pozo,et al.  Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics , 2008, Journal of cellular and molecular medicine.

[109]  David S. Wishart,et al.  Quantitative metabolomics using NMR , 2008 .

[110]  John L Markley,et al.  Metabolite identification via the Madison Metabolomics Consortium Database , 2008, Nature Biotechnology.

[111]  A. Vertes,et al.  Atmospheric pressure infrared MALDI imaging mass spectrometry for plant metabolomics. , 2008, Analytical chemistry.

[112]  R. Weinshilboum,et al.  Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.

[113]  F. Gage,et al.  Identification of small molecules from human embryonic stem cells using metabolomics. , 2007, Stem cells and development.

[114]  Yoshihiro Yamanishi,et al.  KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..

[115]  J. Selbig,et al.  Metabolite profile analysis: from raw data to regression and classification. , 2007, Physiologia plantarum.

[116]  A. Fernie The future of metabolic phytochemistry: larger numbers of metabolites, higher resolution, greater understanding. , 2007, Phytochemistry.

[117]  Tomoyoshi Soga,et al.  Metabolome analysis by capillary electrophoresis-mass spectrometry. , 2007, Journal of chromatography. A.

[118]  B. van Ravenzwaay,et al.  The use of metabolomics for the discovery of new biomarkers of effect. , 2007, Toxicology letters.

[119]  I. Wilson,et al.  Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. , 2007, Journal of proteome research.

[120]  E Holmes,et al.  The mechanism of galactosamine toxicity revisited; a metabonomic study. , 2007, Journal of proteome research.

[121]  Joachim Selbig,et al.  pcaMethods - a bioconductor package providing PCA methods for incomplete data , 2007, Bioinform..

[122]  R. Kauppinen,et al.  A metabolomics perspective of human brain tumours , 2007, The FEBS journal.

[123]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[124]  J. Idle,et al.  LC-MS-Based Metabolomics in Drug Metabolism , 2007, Drug metabolism reviews.

[125]  O. Singh Proteomics and metabolomics: The molecular make‐up of toxic aromatic pollutant bioremediation , 2006, Proteomics.

[126]  Elaine Holmes,et al.  Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. , 2006, Journal of proteome research.

[127]  R. A. van den Berg,et al.  Centering, scaling, and transformations: improving the biological information content of metabolomics data , 2006, BMC Genomics.

[128]  Corey D Broeckling,et al.  MET-IDEA: data extraction tool for mass spectrometry-based metabolomics. , 2006, Analytical chemistry.

[129]  Vladimir Shulaev,et al.  Metabolomics technology and bioinformatics , 2006, Briefings Bioinform..

[130]  John C. Lindon,et al.  Metabolomics Standards Workshop and the development of international standards for reporting metabolomics experimental results , 2006, Briefings Bioinform..

[131]  A. G. Heidema,et al.  The challenge for genetic epidemiologists: how to analyze large numbers of SNPs in relation to complex diseases , 2006, BMC Genetics.

[132]  Weida Tong,et al.  An integrated study of acute effects of valproic acid in the liver using metabonomics, proteomics, and transcriptomics platforms. , 2006, Omics : a journal of integrative biology.

[133]  Matej Oresic,et al.  MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data , 2006, Bioinform..

[134]  Robert S Plumb,et al.  Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. , 2006, Analytical chemistry.

[135]  R. Abagyan,et al.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.

[136]  Ramón Díaz-Uriarte,et al.  Gene selection and classification of microarray data using random forest , 2006, BMC Bioinformatics.

[137]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[138]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.

[139]  Elaine Holmes,et al.  The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. , 2005, Pharmacogenomics.

[140]  Ben van Ommen,et al.  Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology , 2005, Expert review of proteomics.

[141]  Hideo Kobayashi,et al.  Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung diseases. , 2005, Chest.

[142]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[143]  Johan Trygg,et al.  High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. , 2005, Analytical chemistry.

[144]  Nigel W. Hardy,et al.  Summary recommendations for standardization and reporting of metabolic analyses , 2005, Nature Biotechnology.

[145]  Donald G Robertson,et al.  Metabonomics in toxicology: a review. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[146]  Ben van Ommen,et al.  Profiles of Metabolites and Gene Expression in Rats with Chemically Induced Hepatic Necrosis , 2005, Toxicologic pathology.

[147]  Yves Gibon,et al.  GMD@CSB.DB: the Golm Metabolome Database , 2005, Bioinform..

[148]  Bruce S. Kristal,et al.  Relative contribution of specific sources of systematic errors and analytical imprecision to metabolite analysis by HPLC–ECD , 2005, Metabolomics.

[149]  Nigel W. Hardy,et al.  A proposed framework for the description of plant metabolomics experiments and their results , 2004, Nature Biotechnology.

[150]  Valérie Zuang,et al.  A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.

[151]  A. Fernie,et al.  Metabolite profiling: from diagnostics to systems biology , 2004, Nature Reviews Molecular Cell Biology.

[152]  G. O. Thomas,et al.  Different Levels of Polybrominated Diphenyl Ethers (PBDEs) and Chlorinated Compounds in Breast Milk from Two U.K. Regions , 2004, Environmental health perspectives.

[153]  J. Griffiths,et al.  Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models. , 2003, Journal of the National Cancer Institute.

[154]  Julian L Griffin,et al.  Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. , 2003, Current opinion in chemical biology.

[155]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[156]  M. Tomita,et al.  Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. , 2003, Journal of proteome research.

[157]  S. Wold,et al.  PLS-regression: a basic tool of chemometrics , 2001 .

[158]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[159]  R. Vré The scope and limitations of a QA system in research , 2000 .

[160]  Stephen E. Stein,et al.  An Integrated Method for Spectrum Extraction and Compound Identification from GC/MS Data , 1999 .

[161]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[162]  S. Stein An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data , 1999 .

[163]  Peter J. Rousseeuw,et al.  Finding Groups in Data: An Introduction to Cluster Analysis , 1990 .

[164]  J. Edward Jackson,et al.  A User's Guide to Principal Components. , 1991 .

[165]  P. Bhatia,et al.  Biotransformation and excretion of methylcyclopentadienyl manganese tricarbonyl in the rat. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[166]  D. Blacker Food for thought. , 2013, JAMA neurology.

[167]  Thomas Hartung,et al.  Food for Thought … Systems Toxicology , 2012 .

[168]  Alexander Raskind,et al.  Statistical methods in metabolomics. , 2012, Methods in molecular biology.

[169]  Thomas Hartung,et al.  Alternative approaches for medical countermeasures to biological and chemical terrorism and warfare. , 2012, ALTEX.

[170]  Veena S. Kasture,et al.  International Journal of Research and Development in Pharmacy and Life Sciences Metabolomics: Current Technologies and Future Trends , 2022 .

[171]  T. Knudsen,et al.  A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. , 2012, ALTEX.

[172]  E. Want,et al.  HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies. , 2011, Analytical chemistry.

[173]  Christophe Junot,et al.  Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review. , 2011, Clinical biochemistry.

[174]  Erwin van Vliet,et al.  Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century. , 2011 .

[175]  Paul Jennings,et al.  Metabolic response to low-level toxicant exposure in a novel renal tubule epithelial cell system. , 2011, Molecular bioSystems.

[176]  T. Yamoto,et al.  A 1H NMR-based metabolomics approach for mechanistic insight into acetaminophen-induced hepatotoxicity. , 2011, Drug metabolism and pharmacokinetics.

[177]  Thomas Hartung,et al.  Food for Thought ... on mapping the human toxome. , 2011, ALTEX.

[178]  Thomas Hartung,et al.  Food for thought...on alternative methods for chemical safety testing. , 2010, ALTEX.

[179]  T. Ebbels,et al.  NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat. , 2010, Journal of proteome research.

[180]  T. Hartung,et al.  A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. , 2008, Neurotoxicology.

[181]  Thomas Hartung,et al.  Food for thought ... on alternative methods for cosmetics safety testing. , 2008, ALTEX.

[182]  戴聿昌,et al.  The microfluidic device , 2008 .

[183]  Steven K. Gibb Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.

[184]  T. Hartung Food for thought ... on validation. , 2007, ALTEX.

[185]  J. Timbrell Metabonomics in Toxicity Assessment , 2005 .

[186]  O. Fiehn Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.

[187]  Robert P Tonge,et al.  Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[188]  Frauke Pohlki,et al.  The Mechanism of the , 2001, Angewandte Chemie.

[189]  Robertson Dg,et al.  High-throughput toxicology: practical considerations. , 2000 .

[190]  D. Robertson,et al.  High-throughput toxicology: practical considerations. , 2000, Current opinion in drug discovery & development.

[191]  I. Krull,et al.  Analytical method development and validation for the academic researcher , 1999 .

[192]  Jo Allan Beran,et al.  Molecular electron ionization cross sections at 70 ev , 1969 .